INHIBITION OF LIN28B IMPAIRS LEUKEMIA CELL GROWTH AND METABOLISM IN ACUTE MYELOID LEUKEMIA

EHA Library, Jianbiao Zhou, 182365

EVALUATION OF MINIMAL RESIDUAL DISEASE IN NPM1-MUTATED AML PATIENTS.

EHA Library, Carolina Martínez-Laperche, 182367

AT101 ELIMINATES AML STEM CELLS VIA ACTIVATION OF INTRINSIC APOPTOTIC PATHWAY AND PARTICIPATION IN DNA DAMAGE RESPONSE

EHA Library, Bing Xu, 182368

COOPERATIVE EFFECT OF CHIDAMIDE AND CHEMOTHERAPEUTIC DRUGS INDUCE APOPTOSIS BY DNA DAMAGE ACCUMULATION AND REPAIR DEFECTS IN ACUTE MYELOID LEUKEMIA STEM AND PROGENITOR CELLS

EHA Library, Bing Xu, 182369

NEW CANDIDATE GENES USEFUL TO PREDICT THE RISK OF RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Jacopo Nanni, 182371

THE EXPRESSION OF SALL4 AND BMI-1 GENES IN MYELOID LEUKEMIA

EHA Library, Mona El-Nagdy, 182372

AN INVESTIGATION INTO THE ROLE OF S100A8 AND S100A9 IN ACUTE MYELOID LEUKAEMIA

EHA Library, Sabah Chaudry, 182373

SUCCESSFUL COVERAGE OF DIFFICULT TO SEQUENCE GENES (CALR, CEBPA, AND FLT3) ASSOCIATED WITH MYELOID DISORDERS USING A HYBRIDISATION-BASED ENRICHMENT APPROACH PRIOR TO NEXT-GENERATION SEQUENCING (NGS).

EHA Library, Graham Speight, 182374

ASSOCIATION OF MIRNA EXPRESSION PROFILES WITH FUNCTIONAL AND MOLECULAR ACUTE MYELOID LEUKEMIA CATEGORIES

EHA Library, *Claudia Sargas, 182375

PROTEOMIC APPROACH TO IDENTIFY MOLECULAR TARGETS OF HALOFUGINONE IN ACUTE MYELOID LEUKEMIA

EHA Library, Larissa Cândido, 182376

DNA METHYLATION AND HYDROXYMETHYLATION PROFILING IS CAPABLE TO DISTINGUISH AML SAMPLES WITH DISTINCT MUTATIONS IN DNA METHYLATION REGULATORY GENES

EHA Library, Hana Hájková, 182377

RNA-MEDIATED CORRECTION OF ABERRANT DNA METHYLATION AT THE P15 LOCUS

EHA Library, Mailin Li, 182378

JQ1 AND CURCUMIN COMBINED TREATMENT SHOWS SYNERGIC EFFECTS IN MLL-REARRANGED LEUKEMIA CELL LINES

EHA Library, Patrizia Vitullo, 182379

TP53Β AND TP53Γ EXPRESSION LEVELS IN RELATION TO NPM1 AND CEBPA MUTATIONS.

EHA Library, Karolina Matiakowska, 182380

EXPRESSION PROFILE OF EPIGENETIC MODULATORS IN ACUTE MYELOID LEUKEMIA OF INTERMEDIATE RISK

EHA Library, Santiago Sánchez Sosa, 182381

FLOW CYTOMETRY IMMUNOPHENOTYPING IN CEBPA-DM DE NOVO AML. BIOLOGIC AND PROGNOSTIC RELEVANCE.

EHA Library, Monica Fernandez, 182382

PROTEOME CHANGES IN ACUTE MYELOID LEUKEMIA PATIENTS BEFORE AND AFTER INDUCTION TREATMENT

EHA Library, Luisa , 182383

AMP-ACTIVATED PROTEIN KINASE ACTIVITY INTERFERES WITH OVEREXPRESSION OF NUCLEOPHOSMIN IN CYTARABINE-INDUCED CHEMORESISTANT AML CELLS

EHA Library, Dana Kim, 182384

QUERCETIN REGULATES TELOMERE-BINDING PROTEINS EXPRESSION OF POT1, TRF1, TRF2 TO INHIBIT PROLIFERATION AND INDUCE APOPTOSIS IN AML THP-1 CELLS

EHA Library, Ruirong Xu, 182385

PPARΓ AGONISTS INHIBIT ADHESION SIGNAL TO ENDOTHELIAL CELLS IN THE DIFFERENTIATION INDUCTION OF HL-60 ACUTE PROMYELOCYTIC LEUKEMIA CELLS.

EHA Library, Jinny Park, 182386

IN VITRO DRUG SENSITIVITY TEST IN THE INDIVIDUALIZED ANTI-LEUKEMIA CHEMOTHERAPY FOR THE NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Sungnam Lim, 182387

PROGNOSTIC IMPACT OF P53 EXPRESSION IN BONE MARROW BIOPSY OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Heloíza Souza, 182388

LONG-TERM FOLLOW-UP OF SALVAGE TREATMENT FOR RELAPSED AML WITH CLADRIBINE, HIGH DOSE CYTARABINE AND IDARUBICIN (CAI)

EHA Library, Karin Mayer, 182390

HIGH EVI1 EXPRESSION PREDICTS POOR OUTCOMES IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS WITH INTERMEDIATE CYTOGENETIC RISK RECEIVING CHEMOTHERAPY ONLY

EHA Library, Qianli Jiang, 182391

EFFICACY AND SAFETY OF DECITABINE IN ELDERLY AML PATIENTS: A REAL LIFE MULTICENTER EXPERIENCE OF THE NETWORK RETE EMATOLOGICA LOMBARDA (REL)

EHA Library, Erika BORLENGHI, 182392

CLOFARABINE, CYTARABINE AND MITOXANTRONE (CLAM) FOR RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA - INTERIM RESULTS OF A PROSPECTIVE PHASE 2 STUDY

EHA Library, Harinder Gill, 182393

FATAL EVOLUTION IN THE FIRST 96 HOURS OF PATIENTS DIAGNOSED WITH ACUTE LEUKEMIA: ANALYSIS OF A SERIES OF 346 CONSECUTIVE CASES OF ACUTE LEUKEMIA IN A SINGLE CENTER

EHA Library, Silvia Martin-Batista, 182394

PRIMARY POSACONAZOLE PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA - A SINGLE CENTER REAL LIFE EXPERIENCE

EHA Library, Tülin Fıratlı Tuğlular, 182395

CLINICAL AND PROGNOSTIC VALUE OF FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS IN ROUTINE CLINICAL PRACTICE - SINGLE CENTER EXPERIENCE

EHA Library, Asiyat Radzhabova, 182396

TARGETING ENDOTHELIAL DYSFUNCTION FOR PROTECTION FROM ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN PATIENTS WITH ACUTE LEUKEMIA AND CO-MORBID ISCHEMIC HEART DISEASE

EHA Library, Tetiana Lymanets, 182397

CLINICAL CHARACTERISTICS AND SURVIVAL OUTCOMES IN ACUTE ERYTHROID LEUKEMIA (AML-M6): AML/MDS WORKING PARTY STUDY OF KOREAN SOCIETY OF HEMATOLOGY

EHA Library, Jae Joon Han, 182398

PREGNANCY ACCUMULATES UNFAVORABLE MOLECULAR GENETIC AML AND SHOULD BE CONSIDERED AS A POOR PROGNOSTIC FACTOR.

EHA Library, Vera Troitskaya, 182399

CLOFARABINE IN RELAPSED-REFRACTORY ACUTE MYELOGENOUS LEUKEMIA: A SINGLE CENTRE EXPERIENCE

EHA Library, Barbara Scappini, 182400

PRESENCE OF MULTIPLE DRIVERS IN THE SELECTION OF HIGH AND LOW INTENSITY CHEMOTHERAPY IN AML

EHA Library, Kalpana Vijayan, 182401

IRAIN LONG NON CODING RNA ARE DOWN-REGULATED IN POOR PROGNOSIS AML PATIENTS

EHA Library, Marjan Yaghmaie, 182402

PERFORMANCE OF THE LEUKOSTRAT® CDX FLT3 MUTATION SIGNAL RATIO ASSAY TO DETECT INTERNAL TANDEM DUPLICATION (ITD) AND TYROSINE KINASE DOMAIN (TKD) MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, April Osgood, 182403

CLINICAL FEATURES AND OUTCOME OF PATIENTS WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Souad Taoussi, 182404

FLOW CYTOMETRY ANALYSIS SOFTWARE FOR REMOTELY LOCATED HAEMATOLOGISTS

EHA Library, Mark Kelly, 182405

FLAG-IDA IN THE TREATMENT OF ACUTE LEUKEMIA: SINGLE-CENTER EXPERIENCE

EHA Library, Maria Isabel Goyanes, 182406

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASMS - UNUSUAL PRESENTATIONS AND UNFAVOURABLE OUTCOMES

EHA Library, Margarita Guenova, 182407

PREDICTIVE RELEVANCE OF CLINICAL CHARACTERISTICS IN PEDIATRIC PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA TREATED AT SINGLE INSTITUTION- REPORT OF AN OUTCOME ANALYSIS.

EHA Library, Suleimman Alsweedan, 182408

IS HIF-2 ALPHA A POOR PROGNOSIS FACTOR IN HUMAN ACUTE MYELOID LEUKEMIA? A SINGLE CENTER ANALYSIS - PRELIMINARY RESULTS

EHA Library, Jaroslaw Dybko, 182409

RARE BCR/ABL FUSION PROTEINS AND THEIR CLINICAL SIGNIFICANCE INTO PH+ ACUTE MYELOID LEUKEMIAS

EHA Library, Monica Piedimonte, 182410

HYPOMETILATING AGENTS (HMA) AS SALVAGE THERAPY IN RELAPSED OR REFRACTORY AML: A 2-CENTERS RETROSPECTIVE STUDY

EHA Library, Federica Lessi, 182411

OMITTING CYTARABINE FROM CHEMOTHERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA REDUCES TOXICITY AND NOT EFFICACY

EHA Library, Eleni Gavriilaki, 182412

DISEASE CHARACTERISTICS AND TREATMENT PATTERNS OF AML PATIENTS <60 YEARS OLD VERSUS ≥60 YEARS OLD

EHA Library, Kalpana Vijayan, 182413

FLT3, NPM1, СЕВРА AND ТР53 MUTATIONS AT ACUTE PROMYELOCYTIC LEUKEMIA: PROGNOSTIC FACTORS AND CORRELATION WITH OTHER MARKERS WITHIN THE PATIENTS OF GOMEL REGION IN BELARUS

EHA Library, Zhanna Kozich, 182414

A UNIQUE PRESENTATION OF ACUTE PROMYELOCYTIC LEUKEMIA: AORTOILIAC OCCLUSIVE DISEASE (LERICHE SYNDROME)

EHA Library, Selin Berk, 182415

A CASE OF THERAPY-RELATED ACUTE LEUKEMIA WITH MIXED PHENOTYPE WITH BCR-ABL1 AFTER TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Dahae Yang, 182416

CROSS-SECTIONAL ANALYSIS OF CONCORDANCE RATES BETWEEN KARYOTYPING AND RT-PCR IN ACUTE MYELOID LEUKEMIA; REAL WORLD CHALLENGES

EHA Library, Deeksha Katoch, 182417

CLINICAL, CYTOMORPHOLOGIC AND IMMUNOPHENO/IMMUNOHISTOCHEMICAL CHARACTERISTICS OF PATIENTS WITH BLASTIC PLASMOCYTOID DENDRITIC CELL NEOPLASM - DIAGNOSTIC AND THERAPEUTIC DILEMMA

EHA Library, Jelena Bila, 182418

ECONOMIC IMPACT AND HEALTHCARE UTILIZATION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN ROUTINE CLINICAL CARE IN THE UNITED STATES (US) - A CLAIMS DATABASE STUDY

EHA Library, Aaron Galaznik, 182419

PHARMACOKINETICS OF RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Barbara Jezeršek Novaković, 182420

HOW 18FDG PET/CT CAN IDENTIFY BONE MARROW INFILTRATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA

EHA Library, Stefania Leone, 182421

LOW ALBUMIN LEVEL CORRELATES WITH POORER SURVIVAL OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: SERBIAN LYMPHOMA GROUP EXPERIENCE

EHA Library, Jelena Jelicic, 182422

TREATMENT PATTERNS AND TREATMENT RESPONSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN ROUTINE CLINICAL CARE IN THE UNITED STATES (US) - A CLAIMS DATABASE STUDY

EHA Library, Aaron Galaznik, 182423

TP53 GENE MUTATIONS IS A PREDICTOR OF HIGH GRADE B-CELL LYMPHOMA PROGRESSION

EHA Library, Anna Misyurina, 182424

HTLV-1 INFECTION INCREASED THE RISK OF OTHER MALIGNANCY

EHA Library, Aya Nakaya, 182425

THIOTEPA BUSULFAN CYCLOPHOSPHAMIDE (TBC), A TOXIC CONDITIONING FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) IN CENTRAL NERVOUS SYSTEM LYMPHOMA (CNSL): REMISSION OR INFECTION?

EHA Library, Lebon Delphine, 182427

TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH RISK AND HIGH-INTERMEDIATE RISK GROUPS

EHA Library, Iryna Kriachok, 182428

PROGNOSTIC MODEL WITH NEUTROPHIL-LYMPHOCYTE RATIO AND PERFORMANCE STATUS IN DIFFUSE LARGE B CELL LYMPHOMA TREATED WITH R-CHOP

EHA Library, Gyeong-Won Lee, 182429

HIGH SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR ARE ASSOCIATED WITH A POOR PROGNOSIS IN CASES OF RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA, NOT OTHERWISE SPECIFIED

EHA Library, Mari Morita, 182430

AUTOIMMUNE DISEASES ARE NOT ASSOCIATED WITH INFERIOR PROGNOSIS IN LYMPHOMA PATIENTS

EHA Library, Yu-Hsuan Shih, 182431

THE DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS OF CIRCULATING MIRNA-21 IN A SAMPLE OF HEPATITIS C/NONEHEPATITIS DIFFUSE LARGE B-CELL LYMPHOMAEGYPTIAN PATIENTS

EHA Library, Mayada A. Moussa, 182432

A NEW SCORING SYSTEM FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA - A RETROSPECTIVE MULTI-CENTER ANALYSIS IN TAIWAN

EHA Library, Yung-Cheng Su, 182433

RELEVANCE OF CIRS SCALE IN THE PROGNOSIS OF DIFFUSE LARGE B CELL LYMPHOMA IN ELDERLY PATIENTS

EHA Library, Carlos Plaza Meneses, 182434

PRIMARY ADRENAL LYMPHOMA: A SINGLE-CENTER EXPERIENCE

EHA Library, LEI YUAN, 182435

EFFICACY AND SAFETY OF IBRUTINIB THERAPY IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN REAL-LIFE - A MULTICENTRIC STUDY (R.E.P. - APULIAN HEMATOLOGY NETWORK)

EHA Library, Vito Pier Gagliardi, 182436

HEMATOLOGICAL MALIGNANCIES IN SOLID ORGAN TRANSPLANT RECIPIENTS: RETROSPECTIVE SINGLE-CENTER ANALYSIS IN JAPAN

EHA Library, Katsuya Fujimoto, 182437

MYC REARRANGEMENT HAS A STRONG PROGNOSTIC IMPACT IN THE FEMALE PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Hideaki Nitta, 182438

ASSESSING THE RISK FOR PERFORATION IN DIFFUSE LARGE B-CELL LYMPHOMA INVOLVING THE INTESTINES USING COMPUTED TOMOGRAPHY CHARACTERISTICS.

EHA Library, Nadav Sarid, 182439

DOUBLE-HIT AND TRIPLE-HIT LYMPHOMAS: TREATMENT AND CLINICAL OUTCOME IN A SINGLE INSTITUTION

EHA Library, Laia Martínez Serra, 182440

EFFECTIVE TREATMENTS ARE REQUIRED FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) WITH PRIMARY REFRACTORY DISEASE

EHA Library, Maria Queralt Salas Gay, 182441

RBAC (RITUXIMAB BENDAMUSTINE CYTARABINE) IS A FEASIBLE AND SAFE INDUCTION REGIMEN PRIOR TO ASCT IN FRONTLINE MCL: A SINGLE CENTER RETROSPECTIVE REAL LIFE EVALUATION

EHA Library, Mitja Nabergoj, 182442

THE SAFETY OF LIPOSOMAL CYTARABINE IN CENTRAL NERVOUS SYSTEM INFILTRATION BY HAEMATOLOGIC MALIGNANCIES

EHA Library, Patricia García Ramírez, 182443

RETROSPECTIVE ANALYSIS OF OUTCOMES FOR ELDERLY PATIENTS WITH STAGE 3 AND 4 DISEASE HIGH-GRADE DLBCL WITH REDUCED CYCLES OF R-CHOP OR R-GCVP : A 7 YEARS SINGLE-INSTITUTE EXPERIENCE.

EHA Library, Mahesh Prahladan, 182444

MULTIPLE NEOPLASMS CONSIST OF SOLID CANCER AND NON-HODGKIN LYMPHOMA

EHA Library, K Natori, 182445

RETROSPECTIVE EVALUATION ON EFFICACY AND FEASIBILITY OF R-CODOX-M/IVAC REGIMEN IN AGGRESSIVE DLBCL

EHA Library, Elisa Coviello, 182446

OLDER PATIENTS WITH DLCLB- BODY MASS INDEX AS A PREDICTOR OF SURVIVAL

EHA Library, Mila Purić, 182447

STOMACH DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE CENTER EXPERIENCE

EHA Library, Meng-Ta Sung, 182448

IMMUNOHISTOCHEMISTRY BIOMARKERS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE STUDY

EHA Library, Paula Cristina Gaspar Brandao de Sousa e Sant, 182449

INVESTIGATION ON TREATMENT STRATEGY, PROGNOSTIC FACTORS, AND RISK FACTORS FOR EARLY DEATH IN ELDERLY TAIWANESE PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, SHIH-FENG CHO, 182450

TREATMENT OUTCOME OF MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA (MEITL): EXPERIENCE FROM AN ASIAN CANCER CENTER

EHA Library, Meng-Ta Sung, 182451

OSTEOPONTIN AS PRONOSTIC FACTOR OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Gilberto Barranco, 182452

TREATMENT OF NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA PATIENTS BASED ON COMORBIDITIES & PERFORMANCE STATUS: A SINGLE-CENTRE EXPERIENCE.

EHA Library, Yeong Jer Lim, 182453

AN AUDIT OF THE USE OF RASBURICASE FOR THE PREVENTION AND TREATMENT OF TUMOUR LYSIS SYNDROME IN PATIENTS RECEIVING TREATMENT AT THE NORTHERN CENTRE FOR CANCER CARE, NEWCASTLE UPON TYNE, UK.

EHA Library, Emily Watts, 182454

IMPLICATION OF BASIC VALUES OF VITAMIN D IN THE CLINICAL COMPLICATIONS OF PATIENTS WITH NO HODGKIN LYMPHOMA IN ACTIVE CHEMOTHERAPY TREATMENT

EHA Library, Rafael Martos Martinez, 182455

PROGNOSTIC IMPACT OF SYNCHRONOUS MULTIPLE PRIMARY MALIGNANT TUMORS ON NEWLY DIAGNOSED LYMPHOMA PATIENTS

EHA Library, Satoshi Nishiwaki, 182456

GLOBAL HEMOSTATIC ASSAY AT DIFFERENT TARGET ACTIVITY OF FACTOR VIII AND FACTOR IX

EHA Library, Kiyoung Yoo, 182457

THE RATE OF SUCCESSFUL IMMUNOTOLERANCE INDUCTION IN HAEMOPHILIA A BOYS TREATED WITH OCTOCOG ALFA - THE EXPERIENCE OF POLISH PAEDIATRIC HAEMOPHILIA CARE CENTRES

EHA Library, Andrzej Koltan, 182458

APPROACH TO PREGNANCY IN NIEMANN PICK DISEASE TYPE B PATIENT

EHA Library, Danijela Agić, 182459

SINGLE CENTRE FX DEFICIENCY EXPERIENCE

EHA Library, ZAFER BASLAR, 182460

IMPROVEMENT OF THE SURVIVAL FOR LIFE-THREATENING HEMORRHAGE WITH HEMOPHILIA PATIENT

EHA Library, Kun Soo Lee, 182461

CAN BLEEDING SCORE AND FACTOR LEVELS DETERMINE HEMOPHILIA CARRIERS?

EHA Library, Yilmaz Ay, 182462

FETAL INTRACRANIAL HEMORRHAGE AS A PRESENTING FEATURE OF SEVERE CONGENITAL FACTOR VII DEFICIENCY: THE NEED FOR EARLY PROPHYLAXIS

EHA Library, Mohamed Elshinawy, 182463

THE ASSOCIATION OF BLOOD TYPE WITH THE NEED FOR TRANSFUSIONS IN PATIENTS WITH VENTRICULAR ASSIST DEVICES

EHA Library, Theoni Kanellopoulou, 182464

ACQUIRED PURE RED CELL APLASIA ASSOCIATED WITH LYMPHOPROLIFERATIVE DISEASES IN ERYTHROPOIETIN-REFRACTORY ANEMIA PATIENTS ON DIALYSIS

EHA Library, Kentaro Yoshinaga, 182465

ADULT PATIENTS WITH ACQUIRED PURE RED CELL APLASIA: TREATED BY CYCLOSPORINE A OR CORTICOSTEROIDS：SIMILAR EFFICIENCY

EHA Library, Guangsheng He, 182466

REACTIVATION OF HEPATITIS B VIRUS INFECTION IN APLASTIC ANEMIA PATIENTS

EHA Library, Guangsheng He, 182467

MULTICENTER RESULTS OF SCHWACHMAN-DIAMOND SYNDROME PATIENTS

EHA Library, Sule Unal, 182468